Organization
Stanford University, Stanford, United States of America
3 abstracts
Abstract
ASSOCIATIONS OF BASELINE CLINICAL AND BIOMARKER FACTORS WITH SYMPTOMS AND FUTURE DEVELOPMENT OF CLINICALLY-APPARENT RHEUMATOID ARTHRITIS IN AN ACPA POSITIVE COHORTOrg: CU Anschutz Medical Campus, Aurora, United States of America, Janssen Research and Development, LLC, Spring House, United States of america, Benaroya Research Institute at Virginia Mason, Seattle, United States of America, University of California San Diego, La Jolla, United States of America, Stanford University, Stanford, United States of America,
Abstract
A FIRST IN CLASS THERAPEUTIC NANOPARTICLE FOR SPECIFIC TARGETING OF ANTI-CITRULLINATED PROTEIN ANTIBODY AMELIORATES SERUM TRANSFER AND COLLAGEN INDUCED ARTHRITISOrg: Danish Technical University, Copenhagen, Denmark, Aarhus University, Aarhus, Denmark, Aarhus University Hospital, Aarhus, Denmark, Amgen, Thousand Oaks, United States of America, Stanford University, Stanford, United States of America,
Abstract
ANTI-CARBAMYLATED ANTIBODIES IN CANADIAN FIRST NATION RA PATIENTS, FIRST DEGREE RELATIVES AND CONTROLS IN RELATION TO ACPA AND RF PRESENCE AND ACPA EPITOPE SPREAD Org: Rheumatology, Leiden University Medical Centre, Leiden, Netherlands, University Erlangen-Nurnberg, Erlangen, Charite Humboldt University, Berlin, Abbott GmbH Co. KG, Ludwigshafen, Germany, Rheumatology, University of Manitoba, Winnipeg, Canada, Stanford University, Stanford, United States of America,